Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Tenon Medical (TNON) EBIAT (2021 - 2025)

Tenon Medical has reported EBIAT over the past 5 years, most recently at -$2.8 million for Q4 2025.

  • For Q4 2025, EBIAT rose 8.26% year-over-year to -$2.8 million; the TTM value through Dec 2025 reached -$12.6 million, up 8.17%, while the annual FY2025 figure was -$12.6 million, 8.17% up from the prior year.
  • EBIAT for Q4 2025 was -$2.8 million at Tenon Medical, up from -$3.3 million in the prior quarter.
  • Over five years, EBIAT peaked at -$201000.0 in Q1 2021 and troughed at -$7.9 million in Q4 2022.
  • A 5-year average of -$3.4 million and a median of -$3.2 million in 2022 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: tumbled 1070.65% in 2022 and later skyrocketed 60.35% in 2023.
  • Year by year, EBIAT stood at -$2.8 million in 2021, then tumbled by 178.15% to -$7.9 million in 2022, then skyrocketed by 60.35% to -$3.1 million in 2023, then grew by 1.5% to -$3.1 million in 2024, then rose by 8.26% to -$2.8 million in 2025.
  • Business Quant data shows EBIAT for TNON at -$2.8 million in Q4 2025, -$3.3 million in Q3 2025, and -$2.8 million in Q2 2025.